Search

everythinglearnresearchcommunity

for

Search:↓

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Finasteride linked to skin inflammation.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Cryptococcoid Sweet syndrome can be linked to hydralazine use and multiple autoantibodies, requiring high clinical suspicion and more research.

COVID-19 can cause various skin issues, helping doctors diagnose it early.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Combining ciclosporin and simvastatin can cause severe kidney damage.

A child with a rare vitamin D-resistant condition improved with treatment.